Pharmaceutical companies are cutting more staff than cash-strapped biotechs, leading to workforce reductions. Pfizer is scouting out its next science chief as there have been big changes in the company’s leadership. There is also a debate over a new side effect tied to the diabetes drug Ozempic. Entrepreneurs Alexis Borisy and Zach Weinberg discuss their biotech incubator Curie.Bio and their goal to “free the founders.” For more information on biotech layoffs, Curie.bio, Pfizer’s leadership changes, Pfizer’s GLP-1 pill plans, and the report about vision loss in people taking semgalutide, visit the provided links. “The Readout LOUD” podcast is available on various platforms.
Source link
Readout LOUD podcast: Biotech layoffs, Pfizer exec departs
